STOCK MARKET BSE NSE

‘Focus on generic pharma products’

Published: 07th December 2012 10:12 AM  |   Last Updated: 07th December 2012 10:12 AM   |  A+A-

APJ-Abdul-Kalam

India has a core competence of producing cost-effective pharma products and should set a target of producing 20 per cent of world generics products, said former President Abdul Kalam.

Speaking after the inauguration of 64th Indian Pharmaceutical Congress at SRM University, here on Thursday, Kalam said the global production of pharmaceuticals, branded and generics put together is more than $550 billion and the Indian pharma industry, which has a turnover of $30 billion, should aim to be a leader in drug production.

Stating that by 2020, the demand for pharmacists will be around 1.7 million in our country, he called for the need for partnership between pharma industries and pharma institutions in drug development and clinical research.He said Indian pharma industrialists have to aggressively shift paradigms and look beyond process development capabilities towards new drug research with adequate attention to quality, costs, and time dimensions. 



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp